stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Revenue
Progyny, Inc.'s revenue for fiscal 2025 was $1.3B, up 10.4% from $1.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.3B. Over the past ten years it has ranged from $48.6M (fiscal 2017) to $1.3B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 8 consecutive fiscal years. Progyny, Inc. ranks 11th of 12 Healthcare Plans companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.3B | 10.40% |
| FY2024 | $1.2B | 7.22% |
| FY2023 | $1.1B | 38.34% |
| FY2022 | $786.9M | 57.19% |
| FY2021 | $500.6M | 45.17% |
| FY2020 | $344.9M | 50.15% |
| FY2019 | $229.7M | 117.92% |
| FY2018 | $105.4M | 116.94% |
| FY2017 | $48.6M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $341.3M | (2.64%) |
| Jun 2026 | $350.5M | 6.70% |
| Mar 2026 | $328.5M | 3.17% |
| Dec 2025 | $318.4M | 1.61% |
| 28 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CI Cigna Group compare | $286.3B |
| CNC Centene Corporation compare | $203.9B |
| ELV Elevance Health, Inc. compare | $201.8B |
| HUM Humana Inc. compare | $154.2B |
| MOH Molina Healthcare, Inc compare | $44.1B |
| OSCR Oscar Health, Inc. compare | $17.5B |
| ALHC Alignment Healthcare, Inc. compare | $4.9B |
| CLOV Clover Health Investments, Corp. compare | $2.7B |
| PGNY Progyny, Inc. | $1.3B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on PGNY
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement